ERBB3 and malignant colon neoplasm: Moreover, we found neither upregulation of HER-3 and GABARAP mRNAs nor activation of the ERK1/2 pathway in the colon cancer cell lines treated with either SB202190 or PH79704 compared to the vehicle (DMSO)-treated cells (Suppl.